Alector, Inc. Files 8-K: Director/Officer Changes & More

Ticker: ALEC · Form: 8-K · Filed: 2025-06-13T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes

Related Tickers: ALTR

TL;DR

Alector's 8-K shows director changes, new officers, and compensation updates.

AI Summary

Alector, Inc. filed an 8-K on June 13, 2025, reporting events as of June 9, 2025. The filing covers the departure of directors, election of new directors, appointment of officers, and updates to compensatory arrangements. It also includes information on matters submitted to a vote of security holders and financial statements/exhibits.

Why It Matters

This filing indicates significant corporate governance changes at Alector, Inc., which could impact strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors and officers, along with compensatory arrangements, can signal shifts in company strategy or internal dynamics.

Key Players & Entities

Alector, Inc. (company) — Registrant
June 9, 2025 (date) — Earliest event reported
June 13, 2025 (date) — Date of report

FAQ

Who has departed from Alector, Inc.'s board or officer positions?

The filing indicates the departure of directors or certain officers, but specific names are not detailed in the provided excerpt.

Were any new directors or officers appointed?

Yes, the filing explicitly mentions the election of directors and the appointment of certain officers.

What is the primary purpose of this 8-K filing for Alector, Inc.?

The filing serves to report current events, including changes in directors and officers, compensatory arrangements, and matters submitted to security holders.

When was the earliest event reported in this filing?

The earliest event reported was on June 9, 2025.

What other types of information are included in this 8-K filing besides personnel changes?

The filing also includes information on compensatory arrangements of certain officers, submission of matters to a vote of security holders, and financial statements and exhibits.

From the Filing

0001193125-25-140731.txt : 20250613 0001193125-25-140731.hdr.sgml : 20250613 20250613160601 ACCESSION NUMBER: 0001193125-25-140731 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250609 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250613 DATE AS OF CHANGE: 20250613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 822933343 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38792 FILM NUMBER: 251046510 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 8-K 1 d58708d8k.htm 8-K 8-K false 0001653087 0001653087 2025-06-09 2025-06-09     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2025     Alector, Inc. (Exact name of Registrant as Specified in Its Charter)       Delaware   001-38792   82-2933343 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.) 131 Oyster Point Blvd. Suite 600   South San Francisco , California     94080 (Address of Principal Executive Offices)     (Zip Code) Registrant’s Telephone Number, Including Area Code: (415) 231-5660   (Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock   ALEC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 9, 2025, Dr. Marc Grasso gave notice of his decision to resign from his position as Chief Financial Officer of Alector, Inc. (“Alector”) in order to pursue other opportunities. His resignation wil